Hemodialysis and Peritoneal Dialysis Market Set to Surpass USD 245 Billion by 2034 at a 8.9% of CAGR

Hemodialysis and Peritoneal Dialysis Market

Hemodialysis and Peritoneal Dialysis Market

The hemodialysis and peritoneal dialysis market is embarking on a transformative journey, with robust growth anticipated well into 2034. Valued at USD 104.3 billion in 2024, the market is projected to exceed a staggering valuation of USD 245 billion by 2034, reflecting a promising compound annual growth rate (CAGR) of 8.9%.

Hemodialysis and peritoneal dialysis are critical therapies for patients suffering from end-stage renal disease (ESRD), providing life-sustaining treatments that remove waste products and excess fluids from the blood. The market’s expansion is driven by increasing prevalence of chronic kidney diseases, rising incidence of diabetes and hypertension globally, and advancements in dialysis technology.

Key factors contributing to market growth include the growing elderly population, improving access to healthcare services, and increasing awareness about kidney health and treatment options. Regions with high rates of diabetes and hypertension are expected to drive significant demand for hemodialysis and peritoneal dialysis solutions, ensuring broader accessibility and improved patient outcomes.

Get your PDF Sample Report:

Key Highlights:

  • Strong Regulatory Framework and Healthcare Infrastructure: North America’s hemodialysis and peritoneal dialysis market is benefiting from the region’s stringent regulatory standards and advanced healthcare infrastructure. Regulatory compliance ensures patient safety and quality of care, while state-of-the-art facilities and technologies facilitate the delivery of effective dialysis treatments.
  • Rising Prevalence of Renal Diseases: The increasing prevalence of renal diseases, including chronic kidney disease (CKD) and end-stage renal disease (ESRD), is driving the demand for hemodialysis and peritoneal dialysis treatments. Factors such as aging populations, lifestyle-related risk factors, and improved diagnostic capabilities contribute to the growing burden of renal conditions, necessitating expanded dialysis services.
  • Technological Advancements and Innovation: Technological advancements in hemodialysis and peritoneal dialysis modalities are enhancing treatment efficacy, patient comfort, and convenience. Innovations such as wearable dialysis devices, home-based dialysis solutions, and remote monitoring systems are reshaping the dialysis landscape, empowering patients to manage their condition more effectively and improve their quality of life.
  • Focus on Personalized and Value-Based Care: The shift towards personalized and value-based care models is driving the adoption of tailored dialysis regimens that optimize patient outcomes and resource utilization. Integrated care approaches, multidisciplinary care teams, and patient-centered initiatives aim to address the holistic needs of individuals with renal diseases, promoting better health outcomes and cost-effective care delivery.

Customization Available:

Key Takeaways : 

  • In the type sector, Hemodialys from the Hemodialys and peritoneal dialysis market are anticipated to flourish at the quickest CAGR of 5.5% through 2032.
  • With a CAGR of 5.7% through 2032, Hospital Dialysis are predicted to grow significantly in the application sector of the Hemodialys and peritoneal dialysis market.
  • The market size for Hemodialys and peritoneal dialysis market in the United States is expected to reach US$ 49.4 Billion by 2032, growing at a CAGR of 6% during the research period.
  • China is anticipated to reach a market size of US$ 10.2 billion in Hemodialys and peritoneal dialysis by 2032, with a CAGR of 5.5% during the forecast period.
  • By 2032, South Korea is expected to reach a market size of US$ 5.3 Billion in Hemodialys and peritoneal dialysis, with a CAGR of 49% during the forecast period.


The major players in the global hemodialys and peritoneal dialysis market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), DaVita Inc. (US), Nipro Corporation (Japan), Cantel Medical Corporation (US), Diaver (US).


  • Mar Cor (Cantel Medical Corporation) announced the release of their unique EON Portable Hemodialys Water System in 2021.
  • Fresenius Medical Care AG & Co. KGaA announced the release of a PVC-free peritoneal dialysis solution bag for home dialysis therapy in 2020.
  • Baxter International Inc. gained FDA clearance for a De Novo application for Theranova dilayzers designed to provide enhanced hemodialys (HDx) treatment in 2020.


By Type:

  • Hemodialys
  • Peritoneal dialysis

By End Use:

  • Hospital Based

By Product:

  • Device
  • Consumables
  • Services

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Gain Full to Market Insights: Purchase Now to Access:

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Matched content

Editor’s pick

Express Press Release Distribution